Genetic analysis later revealed a 1.24 Mb deletion at 9p24.3 that involved the DMRT1, DMRT2, DMRT3, and KANK1 genes (exons 2 and 12), which allowed the clinical picture to be classified among the 9p‐deletion syndromes. This evidence concerns the gene DMRT3 and Down syndrome.